Distribution of fragile X mental retardation protein in the human auditory brainstem
Introduction
Fragile X mental retardation protein (FMRP) is the product of the Fmr1 gene and is widely expressed in multiple tissues from the embryonic period into adulthood (Hinds et al., 1993). FMRP is an RNA-binding protein that functions mainly in activity-dependent translational regulation of a large number of mRNAs, including Kv3.1b and slack potassium channels, and is found both pre and post-synaptically (Akins et al., 2009, Akins et al., 2012, Strumbos et al., 2010, Zhang et al., 2012). Although, translation-independent actions of FMRP have recently been discovered (Brown et al., 2010, Zhang et al., 2012, Deng et al., 2013). In the adult, FMRP is widely expressed in epithelia [e.g. seminiferous tubules of the testis; esophagus] and nervous tissue (Hinds et al., 1993). In the brain, FMRP is expressed in neurons and glia throughout the brainstem, forebrain and cerebellum (Hinds et al., 1993, Feng et al., 1997, Wang et al., 2004, Jacobs et al., 2012), although not ubiquitously (Devys et al., 1993).
Fragile X syndrome (FXS) is the most common inherited form of intellectual disability (Bassell and Warren, 2008) and results from a CGG triplet repeat expansion in the Fmr1 gene (Verkerk et al., 1991) and consequent repression of FMRP. FXS affects 1:3600 males and 1:8000 females (Cornish et al., 2008), is the most common genetic cause of autism (Bassell and Warren, 2008) and 15–30% of all FXS patients demonstrate autistic behaviors (Rogers et al., 2001, Hatton et al., 2006, Harris, 2011). Patients with FXS display cognitive disabilities, social deficits including language delays, seizures, autistic features, sensory hypersensitivity and hyperactivity (Eliez et al., 2001, Berry-Kravis, 2002, Hagerman et al., 2009). FXS is associated with a number of CNS dysmorphologies, including reduced volume of the cerebellar vermis, enlargement of the 4th ventricle (Mostofsky et al., 1998, Hoeft et al., 2010) and hypertrophy of the hippocampus (Kates et al., 1997) and caudate nucleus (Reiss et al., 1995, Eliez et al., 2001, Hoeft et al., 2010). Alterations in synaptic structure and function have been identified in FXS patients and animal models of FXS (e.g. Fmr1 knockouts [Fmr1 KO]; Pfeiffer and Huber, 2009) and a number of presynaptic and postsynaptic proteins have abnormal levels in Fmr1 KO (Li et al., 2002, Klemmer et al., 2011). Furthermore, in FXS and Fmr1 KO there is a high density of immature dendritic spines (human – Rudelli et al., 1985, Hinton et al., 1991, Comery et al., 1997, Irwin et al., 2000; mouse – Nimchinsky et al., 2001, Galvez et al., 2003). Cultured hippocampal neurons from Fmr1 KO mice give rise to shorter dendrites with fewer dendritic spines compared to controls (Braun and Segal, 2000, Castren et al., 2005) and FMRP-deficient mice have abnormally arranged dendritic fields in the somatosensory cortex (Galvez et al., 2003), more primary dendrites in the olfactory bulbs (Galvez et al., 2005) and spinal motor neurons with immature dendritic arbors (Thomas et al., 2008). Fmr1 KO flies also demonstrate significant overgrowth of dendrites and axons (Zarnescu et al., 2005). These results, taken together, suggest that FMRP plays a role essential to normal maturation and function of the central nervous system.
In our previous post-mortem studies of the autistic brain, we examined the brainstem of a 32-year-old male diagnosed with autism and FXS (Kulesza and Mangunay, 2008). In this case, we observed neurons in the medial superior olive (MSO), a prominent brainstem nucleus which contains coincidence detector neurons that function in sound source localization and encoding temporal features of sound, to be significantly smaller (a nearly 50% reduction in cell body area) and significantly more round (i.e. immature) compared to an age-matched control (Kulesza and Mangunay, 2008). Moreover, there was significantly more variability in the orientation of these MSO neurons in the FXS/autism brain compared to an age-matched control. In addition, we have demonstrated that FMRP is highly expressed in brainstem coincidence detector neurons across species including the nucleus laminaris of alligator and chicken and the MSO in gerbils and human (Wang et al., 2013). Together, we interpret the dysmorphology of MSO neurons in FXS and the abundance of FMRP in the MSO to suggest that auditory-processing deficits in FXS result, at least in part, from dysfunction of brainstem centers. Further, it is believed that the cell types which express FMRP are the most severely impacted in FXS (Hinds et al., 1993) and we hypothesize that FMRP is widely expressed in neuronal cell bodies and dendritic arbors in the cochlear nuclei and superior olivary complex (SOC). Additionally, FMRP is known to play an important role in activity-dependent regulation and tonotopic expression of the Kv3.1b potassium channel in the auditory brainstem and the tonotopic gradient of Kv3.1b expression is required for accurate coding of complex sounds (Strumbos et al., 2010). To examine the distribution of FMRP in the human auditory brainstem and explore possible functional deficits in FXS, we have used immunohistochemistry and confocal microscopy to map the distribution of FMRP in control human dorsal and ventral cochlear nuclei (DCN and VCN) and SOC. Furthermore, we have examined the colocalization of FMRP and Kv3.1b in the MSO.
Section snippets
Tissue sectioning
This report is based on the examination of brainstems from seven individuals ranging in age from 57 to 96 years of age (average 78.6 ± 5.9 years; five female/two male). Table 1 shows the age, cause of death and post-mortem interval for specimens used in this study. All specimens were obtained with permission from the PA Humanities Gifts Registry. Brainstems were only included in this study if they met the following criteria: (1) the cause of death was not neurological, (2) there were no signs of
General brainstem distributions
In order to obtain a more global understanding of the neuronal distribution of FMRP in the human brainstem, we estimated the number of FMRP+ neurons in nuclei along the rostro-caudal length of the brainstem. Specifically, we examined FMRP expression in the principal nucleus of the inferior olive (IO), facial nucleus (FN), MSO, pontine nuclei (PN) and the abducens nucleus (AbN). We found that the vast majority of neurons in the FN and MSO were FMRP+ (Fig. 1; 85 ± 9% and 82 ± 9%, respectively; mean ±
Discussion
To the best of the authors’ knowledge, this is the first quantitative investigation of FMRP-immunolabeling in the human brainstem and the first characterization of FMRP+ neurons in the human cochlear nucleus and SOC. We have identified FMRP+ neurons in each of the brainstem nuclei we investigated, but the proportion varied considerably by nucleus. Specifically, we found that nearly 85% of FN neurons but only about 13% of neurons in the principal nucleus of the IO were FMRP+. We interpret these
Conflict of interest
The authors declare that there are no conflicts of interest.
Acknowledgments
This work was supported in part by a grant from the Lake Erie Consortium for Osteopathic Medical Training. The authors would like to thank Jerome McGraw, Kristen Ruby and George Grignol for technical assistance.
References (84)
- et al.
Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function
Neuron
(2008) - et al.
The mGluR theory of fragile X mental retardation
Trends Neurosci
(2004) - et al.
Fragile X mice develop sensory hyperactivity to auditory stimuli
Neuroscience
(2001) - et al.
Decreased expression of the GABAA receptor in fragile X syndrome
Brain Res
(2006) - et al.
FMRP regulates neurotransmitter release and synaptic information transmission by modulating action potential duration via BK channels
Neuron
(2013) - et al.
Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse
Neurosci Lett
(2005) - et al.
Somatosensory cortical barrel dendritic abnormalities in a mouse model of the fragile X mental retardation syndrome
Brain Res
(2003) - et al.
Olfactory bulb mitral cell dendritic pruning abnormalities in a mouse model of the Fragile-X mental retardation syndrome: further support for FMRP’s involvement in dendritic development
Brain Res Dev Brain Res
(2005) - et al.
Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model
Neurobiol Dis
(2006) - et al.
Dynamics of binaural processing in the mammalian sound localization pathway – the role of GABA(B) receptors
Hear Res
(2011)